Monday, April 24, 2017 4:08:24 PM
Everyone just holding in a 'set and forget' pattern right now.
It isn't exciting or sexy trading to watch, but it is positive IMO. If there was a strong sentiment that the RMAT approval was hot air or expected to be denied, it would have dropped hard by now.
So all is well, just a bit boring - although I haven't seen much else in the market to get pumped over otherwise. New admin put a damper on the MJ sector and practically every export or oil upstart is too volatile to trust.
So here we are in biotech and stem cell research. Somehow the old codgers found a way to like something that would extend their life spans, go figure.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM